Michiel M Smeenk
4PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 23, 2025
Response to: Correspondence on 'Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer-a real-world, retrospective bicenter cohort study' by Wang.Michiel M Smeenk, Vincent van der Noort, Jeroen J M A Hendrikx
|Jul 23, 2025
Response to: Comment on 'Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study' by Zhu.Michiel M Smeenk, Vincent van der Noort, Jeroen J M A Hendrikx
|Feb 06, 2025
Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study.Michiel M Smeenk, Vincent van der Noort, Jeroen M A Hendrikx
|Jan 17, 2025
Tremelimumab plus Durvalumab prior to Chemoradiotherapy in Unresectable, Locally Advanced Non-Small Cell Lung Cancer: The Induction Trial.Michiel M Smeenk, Judi N A van Diessen, Thierry N Boellaard
Pageof 1
Frequent Collaborators
1 joint publications
Judi N A van Diessen
1 joint publications
Thierry N Boellaard
1 joint publications
Koen J Hartemink
1 joint publications
Jeltje F de Vries
1 joint publications
Vincent van der Noort
1 joint publications
Sushil K Badrising
1 joint publications
Emilia C Owers
1 joint publications
Kim Monkhorst
1 joint publications
Michel M van den Heuvel
1 joint publications
Willemijn S M E Theelen
